Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization.
Journal of asthma and allergy(2023)
摘要
ClinicalTrials.gov Identifier: NCT02414854.
更多查看译文
关键词
allergic asthma,dupilumab,perennial aeroallergen,type 2 asthma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要